Krispy Kreme, Inc.
Krispy Kreme, Inc. (DNUT) Financial Performance & Income Statement Overview
Analyze Krispy Kreme, Inc. (DNUT) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Krispy Kreme, Inc. (DNUT) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Krispy Kreme, Inc. DNUT financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $375.18M | $404.02M | $379.87M | $438.81M |
| Cost of Revenue | $90.74M | $98.48M | $95.84M | $354.95M |
| Gross Profit | $284.45M | $305.55M | $284.03M | $83.86M |
| Gross Profit Ratio | $0.76 | $0.76 | $0.75 | $0.19 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $69.64M | $79.64M | $81.79M | $76.88M |
| Operating Expenses | $304.72M | $317.05M | $300.03M | $75.18M |
| Total Costs & Expenses | $395.45M | $415.52M | $395.87M | $430.13M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $16.20M | $15.60M | $16.28M | $14.45M |
| Depreciation & Amortization | $33.90M | $34.03M | $31.38M | $34.60M |
| EBITDA | $14.15M | $25.09M | $102.91M | $41.46M |
| EBITDA Ratio | $0.04 | $0.06 | $0.27 | $0.09 |
| Operating Income | -$20.27M | -$11.50M | -$16.004M | $8.68M |
| Operating Income Ratio | -$0.05 | -$0.03 | -$0.04 | $0.02 |
| Other Income/Expenses (Net) | -$15.80M | -$19.76M | $71.25M | -$15.40M |
| Income Before Tax | -$36.07M | -$24.54M | $55.25M | -$8.54M |
| Income Before Tax Ratio | -$0.10 | -$0.06 | $0.15 | -$0.02 |
| Income Tax Expense | -$2.67M | -$2.38M | $17.68M | -$3.61M |
| Net Income | -$33.28M | -$22.44M | $39.56M | -$5.49M |
| Net Income Ratio | -$0.09 | -$0.06 | $0.10 | -$0.01 |
| EPS | -$0.20 | -$0.13 | $0.23 | -$0.03 |
| Diluted EPS | -$0.20 | -$0.13 | $0.23 | -$0.03 |
| Weighted Avg Shares Outstanding | $170.29M | $169.99M | $169.60M | $169.09M |
| Weighted Avg Shares Outstanding (Diluted) | $170.29M | $169.99M | $171.49M | $169.09M |
The company's financials show resilient growth, with revenue advancing from $438.81M in Q2 2024 to $375.18M in Q1 2025. Gross profit remained healthy with margins at 76% in Q1 2025 compared to 19% in Q2 2024. Operating income hit -$20.27M last quarter, sustaining a consistent -5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $14.15M. Net income dropped to -$33.28M, while earnings per share reached -$0.20. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan